Search

Your search keyword '"Elzi, L"' showing total 476 results

Search Constraints

Start Over You searched for: Author "Elzi, L" Remove constraint Author: "Elzi, L"
476 results on '"Elzi, L"'

Search Results

1. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

2. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

3. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

4. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

5. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

6. Time Trends in Causes of Death in People With Human Immunodeficiency Virus: Insights From the Swiss HIV Cohort Study

7. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

8. A case of ulceroglandular tularemia presenting with lymphadenopathy and an ulcer on a linear morphoea lesion surrounded by erysipelas

9. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

10. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

11. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

12. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

13. Healthcare delivery for HIV-positive people with tuberculosis in Europe

14. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

15. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

17. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

18. Health care provider communication training in rural Tanzania empowers HIV‐infected patients on antiretroviral therapy to discuss adherence problems

19. Ethnicity predicts viral rebound after travel to the tropics in HIV‐infected travelers to the tropics in the Swiss HIV Cohort Study

20. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

22. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

23. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

24. A highly virulent variant of HIV-1 circulating in the Netherlands

25. Children living with HIV in Europe: do migrants have worse treatment outcomes?

26. Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

27. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

29. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study

30. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

32. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

33. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

34. Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[18F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis

35. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

37. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection

38. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

40. Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland

42. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

45. Healthcare delivery for HIV-positive people with tuberculosis in Europe

46. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

50. Ageing with HIV: medication use and risk for potential drug–drug interactions

Catalog

Books, media, physical & digital resources